Clinical Trials Browser

Phase 2 × Waldenstrom Macroglobulinemia × antineoplaston A10 × Clear all

NCT00003512 2018-02-05

Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstrom's Macroglobulinemia

Phase 2 Withdrawn

Waldenstrom Macroglobulinemia